ArcelorMittal Liberia (AML), in partnership with the Government of Liberia, has announced the launch of the 10th batch of its Advanced Academic Scholarship Program with a call for applications by ...

Get the latest on Curis, Inc.’s Q3 2025 earnings, clinical trial milestones, and investment outlook in rare lymphoma and CLL.

Received $54.6 Million in Gross Proceeds from Warrant Exercises: In September and October 2025, SELLAS received a total of approximately $54.6 million in gross proceeds from the immediate exercise of ...

Global fintech giant Visa will roll out a new pilot program that allows businesses to make payments to individual stablecoin ...

The drug was developed through a global strategic collaboration between Kura Oncology and Kyowa Kirin Co., Ltd. (TSE:4151). Under the partnership, Kura leads development, regulatory, and commercial ...

The Czech National Bank (CNB) has purchased Bitcoin and other digital assets worth $1 million, calling it a “test portfolio,” ...

Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response activity tracking ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

Updated clinical development strategy based on positive data In the third quarter of 2025, Mendus shaped up its clinical development plans for the lead program vididencel in myeloid malignancies.The u ...

Panelists discuss how emerging therapies like menin inhibitors show promise based on strong preclinical data and clinical responses, while CD47 inhibitors have faced setbacks in phase 3 trials, with ...

TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients ...

Leaked letters posted on X reveal BakerHostetler accused Sen. Elizabeth Warren of defaming Binance founder Changpeng Zhao ...